National HIV CurriculumLogo

HIV Clinical Care Question Bank

Opportunistic Infections: PreventionQuestion 10/10

A 25-year-old woman was diagnosed with HIV 8 months ago. Her initial laboratory studies showed a CD4 count of 92 cells/mm3 and a positive Toxoplasma IgG. Because of her history of a rash to trimethoprim-sulfamethoxazole, she received atovaquone as prophylaxis for Pneumocystis pneumonia and Toxoplasma encephalitis. She reports excellent adherence with antiretroviral therapy and atovaquone.

Which one of the following would be a criterion for discontinuing primary prophylaxis for Toxoplasma encephalitis in an individual taking antiretroviral therapy?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
May 8th, 2026

This question requires improvement because:


Comment further on how to improve this question or summary:



The Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS) provided financial support for this website. The award provided 100% of total costs and totaled $1,172,990. The contents are those of the author. They may not reflect the policies of HRSA, HHS, or the U.S. Government.

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.